CPhI 2022, the world`s leading pharma event, has just come to an end. It was wonderful to meet our valued customers and partners in person again. Our experts enjoyed three very successful days full of exciting meetings and inspiring discussions. It was a great pleasure to present TIEFENBACHER GROUP´s latest ideas to make pharmaceuticals more affordable, more available, and better than before.  

Thanks a lot for visiting us at our new booth representing TIEFENBACHER GROUP as a global health pioneer. We are already looking forward to seeing you next year in Barcelona at CPhI 2023!

You couldn’t come to the CPhI? Do not hesitate to contact us via info@aet.eu to learn more about our product portfolio and innovative health care solutions – or visit us on: www.tiefenbachergroup.com

About Tiefenbacher Group– Pioneering Healthcare since 1963 
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines  around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our goal is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.  

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email atinfo@tiefenbacher.com